Diadema Partners LP Keros Therapeutics, Inc. Transaction History
Diadema Partners LP
- $383 Billion
- Q1 2025
A detailed history of Diadema Partners LP transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Diadema Partners LP holds 147,100 shares of KROS stock, worth $2.22 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
147,100
Previous 63,547
131.48%
Holding current value
$2.22 Million
Previous $1.01 Billion
49.01%
% of portfolio
0.39%
Previous 0.43%
Shares
1 transactions
Others Institutions Holding KROS
# of Institutions
178Shares Held
36.4MCall Options Held
938KPut Options Held
1.39M-
Nuveen, LLC Charlotte, NC3.95MShares$59.6 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.6MShares$39.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.57MShares$38.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.51MShares$38 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA2MShares$30.2 Million3.97% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $389M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...